Adaptive plasticity of IL-10 + and IL-35 + T reg cells cooperatively promotes tumor T cell exhaustion

Regulatory T cells (T cells) maintain host self-tolerance but are a major barrier to effective cancer immunotherapy. T cells subvert beneficial anti-tumor immunity by modulating inhibitory receptor expression on tumor-infiltrating lymphocytes (TILs); however, the underlying mediators and mechanisms...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature immunology 2019-06, Vol.20 (6), p.724
Hauptverfasser: Sawant, Deepali V, Yano, Hiroshi, Chikina, Maria, Zhang, Qianxia, Liao, Mengting, Liu, Chang, Callahan, Derrick J, Sun, Zhe, Sun, Tao, Tabib, Tracy, Pennathur, Arjun, Corry, David B, Luketich, James D, Lafyatis, Robert, Chen, Wei, Poholek, Amanda C, Bruno, Tullia C, Workman, Creg J, Vignali, Dario A A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Regulatory T cells (T cells) maintain host self-tolerance but are a major barrier to effective cancer immunotherapy. T cells subvert beneficial anti-tumor immunity by modulating inhibitory receptor expression on tumor-infiltrating lymphocytes (TILs); however, the underlying mediators and mechanisms have remained elusive. Here, we found that the cytokines IL-10 and IL-35 (Ebi3-IL-12α heterodimer) were divergently expressed by T cell subpopulations in the tumor microenvironment (TME) and cooperatively promoted intratumoral T cell exhaustion by modulating several inhibitory receptor expression and exhaustion-associated transcriptomic signature of CD8 TILs. While expression of BLIMP1 (encoded by Prdm1) was a common target, IL-10 and IL-35 differentially affected effector T cell versus memory T cell fates, respectively, highlighting their differential, partially overlapping but non-redundant regulation of anti-tumor immunity. Our results reveal previously unappreciated cooperative roles for T cell-derived IL-10 and IL-35 in promoting BLIMP1-dependent exhaustion of CD8 TILs that limits effective anti-tumor immunity.
ISSN:1529-2916
DOI:10.1038/s41590-019-0346-9